الصفحة الرئيسية>>Signaling Pathways>> Immunology/Inflammation>> FKBP>>SLF

SLF (Synonyms: Synthetic Ligand of FKBP)

رقم الكتالوجGC44899

SLF عبارة عن يجند صناعي لبروتين رابط FK506 (FKBP) مع تقارب 3.1 ميكرومتر لـ FKBP51 و IC50 بمقدار 2.6 ميكرومتر لـ FKBP12يمكن استخدام SLF في تركيب PROTAC

Products are for research use only. Not for human use. We do not sell to patients.

SLF التركيب الكيميائي

Cas No.: 195513-96-3

الحجم السعر المخزون الكميّة
5 mg
76٫00
متوفر
10 mg
143٫00
متوفر
50 mg
571٫00
متوفر
100 mg
949٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

FK-506 is a potent immunosuppressant that forms a high affinity complex (Ki = 0.2 nM) with FK-506 binding protein 12 (FKBP12). This complex inhibits the activity of the calcium/calmodulin-dependent protein phosphatase, calcineurin, leading to disruption of T-cell activation. Synthetic ligand of FKBP (SLF) is a cell-permeable analog of FK-506 that binds tightly to FKBP but lacks the ability to inhibit calcineurin. By itself, SLF does not exhibit a significant cellular response. However, homodimers of SLF or heterodimers with another protein ligand, provide a method to promote the dimerization of ligand-specific fusion proteins to induce signaling events within a cellular environment. For example, SLF monomers connected with a 10-atom linker activates Fas signaling via Fas-FKBP fusion proteins with an EC50 of 6 nM.

مراجعات

Review for SLF

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SLF

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.